Prot# D9120C00027: Validation of Patient-Reported Outcome Measures for the Assessment of GERD Symptoms and Their Subsequent Impact on Patients with a Partial Response to PPI Treatment in a Two Part Multi-Center Phase IIA Study Including a Four Week Random

Project: Research project

Project Details

Effective start/end date10/20/0810/20/11


  • AstraZeneca Pharmaceuticals LP (D9120C00027)